
Is Business Broken?
Why Cell and Gene Therapies Cost So Much – And What Can Be Done
Oct 3, 2024
30:29
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- The high costs of cell and gene therapies are largely due to their bespoke nature and the extensive resources required for their development.
- Insurance companies face significant challenges in covering these therapies due to limited clinical trial data and the complexities of treatment eligibility.
Deep dives
The High Costs of Gene and Cell Therapies
Gene and cell therapies are notably expensive, often costing from hundreds of thousands to millions of dollars per treatment. These high prices mainly stem from their bespoke nature, as therapies are custom-made to fit individual patient needs, much like tailor-made suits rather than mass-produced products. The underlying value those therapies provide also factors into their pricing, especially when addressing rare diseases that lack previous treatment options. While these costs may seem exorbitant compared to traditional medications, they reflect the significant resources invested in their development and the hope they represent for patients with no other alternatives.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.